Neoadjuvant radiation study for one-sided breast cancer
Part of Cancer, Skin clinical trials.
This Phase 3 study tests a specific plan that combines chemotherapy (and sometimes targeted medicines) with radiation before surgery for one breast. It may help shrink breast cancer and improve treatment timing, based on how well tumors respond.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have invasive breast cancer in only one breast
- Your doctors plan for you to receive radiation as part of treatment
- You are a woman age 18 or older and can give informed consent
- You can receive chemotherapy before surgery (sometimes with added targeted medicines)
- You should not have distant (far-away) cancer spread
- You must have no major medical issues that would make chemo or pre-surgery radiation unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how breast reconstruction works when radiation is planned around the time of surgery, including in some people before surgery depending on lymph node results. It may help improve safety and outcomes for people needing mastectomy and chest/radiation therapy.
This trial tests a shorter course of radiation to just part of the breast before surgery for women who have had breast cancer return in the same breast. It's for those who have already had radiation to that breast and have a specific type of cancer (ER+, HER2-).
This study tests combining chemotherapy before surgery with radiation therapy before surgery for locally advanced breast cancer. The goal is to see if this approach can improve outcomes, especially for patients whose tumors didn't shrink enough with initial chemo.
This trial is testing a new treatment approach for patients with a certain type of breast cancer (HR+/HER2-). It combines radiation therapy with chemotherapy and an immunotherapy drug before the patient's main surgery, to see if it can shrink or eliminate the tumor more effectively.
This trial tests a new approach for breast cancer that combines a short course of focused radiation (SBRT) with an injection of the immunotherapy drug pembrolizumab directly into the tumor, followed by standard chemotherapy before surgery. The goal is to see if this combination helps shrink the tumor more effectively before surgery.
This study tests whether giving radiation therapy along with standard medical treatment before surgery can improve outcomes for early-stage breast cancer. It aims to see if this combination is safe and effective.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.